The practice of a pharmaceutical company assuming responsibility for the assessment of its vendors is a critical element in ensuring product quality and regulatory compliance. This oversight typically involves a rigorous examination of a supplier’s processes, procedures, and facilities to verify adherence to established standards and guidelines.
Such due diligence offers several advantages. It provides enhanced control over the supply chain, mitigating risks associated with substandard materials or manufacturing practices. Furthermore, it strengthens confidence in the integrity of the final product and contributes to maintaining patient safety. Historically, these audits were often outsourced, but increased focus on supply chain transparency has led to more direct oversight.
